Jane Mitchell

Jane Mitchell is a professor of pharmacology in clinical care medicine at Imperial College London.^[1] Her research focusses on the regulation of cardiovascular health and disease, with a particular interest in endothelial cells, prostacyclin (a platelet activator and vasodilator), and nitric oxide.^[2]

She finished her PhD with Nobel Laureate John Vane and worked as a postdoctoral fellow with another Nobel Laureate: Ferid Murad. She became a professor when she was 38.^[2] Mitchell won the Novartis Prize for Pharmacology in 1999 for her work on cyclooxygeanse biology.^[1] In 2012, she won the AstraZeneca Prize for Women in Pharmacology.^[3]

Mitchell grew up in a coal mining town. People around her frequently died young from cardiovascular and respiratory diseases, which inspired her to pursue a career in clinical research, with a focus on hearts and lungs.^[2] She studied biological sciences at Lancaster University.^[2]

References

^ ^a ^b "Professor Jane Mitchell". www.imperial.ac.uk. Retrieved 2024-03-09.
^ ^a ^b ^c ^d "Meet the First Authors". Circulation Research. 125 (9): 784–786. 2019-10-11. doi:10.1161/RES.0000000000000304. ISSN 0009-7330.
^ "Annual Review 2012" (PDF). British Pharmalogical Society. 2012. Retrieved 8 March 2024.

Zdroj:https://en.wikipedia.org?pojem=Jane_Mitchell
Text je dostupný za podmienok Creative Commons Attribution/Share-Alike License 3.0 Unported; prípadne za ďalších podmienok. Podrobnejšie informácie nájdete na stránke Podmienky použitia.

[:1-1] "Professor Jane Mitchell". www.imperial.ac.uk. Retrieved 2024-03-09.

[Circulation_Research-2] "Meet the First Authors". Circulation Research. 125 (9): 784–786. 2019-10-11. doi:10.1161/RES.0000000000000304. ISSN 0009-7330.

[3] "Annual Review 2012" (PDF). British Pharmalogical Society. 2012. Retrieved 8 March 2024.

[1]

[2]

[3]